Cogstate jumps 51pc on Alzheimer’s drug news
MELBOURNE: Shares in Cogstate, a neuroscience technology company backed by the Myer family, rocketed 60… read more
New Alzheimer’s drug unlikely to be approved in Australia
CANBERRA: A controversial new drug that has offered hope to Alzheimer’s sufferers by slowing cognitive… read more
George Razay to bring dementia lecture to Launceston June 5
LAUNCESTON: The groundbreaking research of Launceston physician George Razay has already changed the way doctors… read more
